Systematic Analysis of the TGF-β-Smad Signaling Pathway in Gastrointestinal Cancer Cells

By Ijichi H.   Ikenoue T.   Kato N.   Mitsuno Y.   Togo G.   Kato J.   Kanai F.   Shiratori Y.   Omata M.  

Biochemical and Biophysical Research Communications, Vol. 289, Iss. 2, 2001-11 ,pp. : 350-357

Elsevier

Access to resources Recommend Favorite

Inhibiting the TGF-β signalling pathway as a means of cancer immunotherapy

By Kirkbride Kellye C   Blobe Gerard C  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 251-261

Informa Healthcare

Access to resources Recommend Favorite

Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-β-induced fibronectin in mesangial cells

By Isono M.   Chen S.   Won Hong S.   Carmen Iglesias-de la Cruz M.   Ziyadeh F.N.  

Biochemical and Biophysical Research Communications, Vol. 296, Iss. 5, 2002-09 ,pp. : 1356-1365

Elsevier

Access to resources Recommend Favorite

Regulation of Smad signalling by protein associations and signalling crosstalk

By Zhang Y.   Derynck R.  

Trends in Cell Biology, Vol. 9, Iss. 7, 1999-07 ,pp. : 274-279

Elsevier

Access to resources Recommend Favorite

Interaction between Smad Anchor for Receptor Activation and Smad3 Is Not Essential for TGF-β/Smad3-Mediated Signaling

By Goto D.   Nakajima H.   Mori Y.   Kurasawa K.   Kitamura N.   Iwamoto I.  

Biochemical and Biophysical Research Communications, Vol. 281, Iss. 5, 2001-03 ,pp. : 1100-1105

Elsevier

Access to resources Recommend Favorite